About the Authors

Alexandra Stanciu

Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

michail.ignatiadis@hubruxelles.be (MI); mariaalexandra.stanciu@ulb.be, maria.alexandra.stanciu@gmail.com (AS)

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Andrea Gombos

Roles Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Elisa Agostinetto

Roles Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Delphine Vincent

Roles Investigation, Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Laurence Buisseret

Roles Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Andreas Papagiannis

Roles Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Francoise Rothe

Roles Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Nicola Occelli

Roles Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Christos Sotiriou

Roles Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

David Venet

Roles Conceptualization, Formal analysis, Methodology, Validation, Writing – review & editing

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Michail Ignatiadis

Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review & editing

michail.ignatiadis@hubruxelles.be (MI); mariaalexandra.stanciu@ulb.be, maria.alexandra.stanciu@gmail.com (AS)

Affiliation Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: EA has received advisory board fees or honoraria from Eli Lilly, AstraZeneca, Abscint, and Bayer; research funding to her institution from Gilead; and meeting or travel grants from Novartis, Roche, Eli Lilly, Daiichi Sankyo, AstraZeneca, Abscint, and Menarini, all outside the submitted work. LB’s salary is partly supported by the Fondation contre le Cancer (Belgium). She has received research funding to her institution from AstraZeneca/MedImmune, has served in advisory roles for Domain Therapeutics, iTeos Therapeutics, and AstraZeneca, is a member of the IMMUcan Consortium (EORTC), and has received travel grants from Gilead, AstraZeneca, Roche, and Eli Lilly. CS reports advisory board roles for Amgen, Astellas, Merck & Co, Seattle Genetics, and Cepheid; invited speaker activities for Exact Sciences and Prime Oncology; travel support from Pfizer and Roche; and stock options and shares in Signatur Biosciences. MI reports consultancy roles for Daiichi Sankyo, AstraZeneca, Menarini/Stemline, Gilead Sciences, Rejuveron Senescence Therapeutics, Pfizer, and Novartis, all outside the submitted work. He has received grant or research support to his institution from Pfizer, Roche, Inivata, and Natera, and has held uncompensated roles within EORTC, including membership of the Board of Directors (2018–2021) and Chair of the Breast Cancer Group (2021–present). AS, AG, DV, FR, AP, NO and DV declare that they have no competing interests.